How to Dose a Peptide Blend: The Math Behind a Multi-Peptide Vial

If you have a vial that lists more than one peptide on the label — a BPC-157 + TB-500 recovery kit, a CJC-1295 + Ipamorelin combo, or a “GLOW” blend of GHK-Cu + BPC-157 + TB-500 — the obvious question is the hard one: how do I dose this thing? You can’t just look up “the dose” for one peptide, because the vial doesn’t contain one peptide. It contains a fixed mixture, and every time you draw from it you pull all of them at the same time.

The math isn’t complicated once you see the structure, and the Peptide Blend Calculator will do the arithmetic for you. But understanding why the numbers work the way they do is what keeps you from making the classic mistake of trying to dose one ingredient of a blend on its own.

The core problem: one volume, everything mixed

A dry blend vial contains a lyophilized (freeze-dried) powder that is a mixture of two or more peptides in a set ratio. You reconstitute it by adding one volume of bacteriostatic water. That single act of adding water dissolves everything together into one solution.

From that point on, the solution is homogeneous. There is no BPC-157 layer and TB-500 layer — the molecules are evenly distributed throughout the liquid. So when you pull, say, 20 units into an insulin syringe, that draw contains a slice of the whole mixture, in exactly the proportion the powder was blended. Draw more and you get more of all of them; draw less and you get less of all of them. You cannot dial up one peptide and dial down another. The ratio is locked in at the factory.

That is the single most important thing to internalize about blends: you dose the blend, not the individual peptides.

The concentration formula

Reconstitution math for a single peptide is straightforward, and the Peptide Reconstitution Calculator covers that case. A blend just applies the same rule to each ingredient in turn, because they all share the same water volume.

For any peptide i in the blend:

Concentration of peptide i = (milligrams of peptide i) ÷ (total mL of bacteriostatic water added)

And for any given draw:

Amount of peptide i delivered = (concentration of peptide i) × (volume of the draw in mL)

The key detail is that the volume term is shared. One draw has one volume, and that same volume multiplies against each peptide’s concentration. That’s the mathematical reason the peptides always come out in a fixed ratio — the ratio of the delivered amounts equals the ratio of the milligrams you started with, no matter how much or how little you draw.

A note on units: insulin syringes are marked in “units” (IU), not mL. On a standard U-100 syringe, 100 units = 1 mL, so 1 unit = 0.01 mL. That’s the conversion that turns a syringe marking into a volume you can put into the formula above.

A worked example (2-peptide blend)

Say you have a vial labeled BPC-157 5 mg + TB-500 10 mg (a deliberately uneven blend, to make the point). You reconstitute it with 3 mL of bacteriostatic water.

First, the concentrations — each peptide’s mg over the shared 3 mL:

Peptide	In vial	÷ shared water	Concentration
BPC-157	5 mg	÷ 3 mL	1.67 mg/mL
TB-500	10 mg	÷ 3 mL	3.33 mg/mL

Now suppose you draw 20 units on a U-100 syringe. That’s 20 × 0.01 = 0.2 mL. Apply the delivery formula to each peptide using that same 0.2 mL:

Peptide	Concentration	× 0.2 mL	Per draw
BPC-157	1.67 mg/mL	× 0.2	0.33 mg (333 mcg)
TB-500	3.33 mg/mL	× 0.2	0.67 mg (667 mcg)

So one 20-unit draw delivers 333 mcg of BPC-157 and 667 mcg of TB-500 — a 1:2 ratio, exactly matching the 5:10 mg you started with. If you decide 333 mcg of BPC-157 is too little and draw double, you also double the TB-500 to 1,334 mcg. There is no draw that gives you more of one without proportionally more of the other. That fixed coupling is the whole story, and it’s why the Peptide Blend Calculator shows a per-peptide breakdown for whatever draw you enter rather than a single number.

Why the fixed ratio is a real limitation

It’s tempting to read “pre-blended” as “convenient.” Sometimes it is. But the flip side is that the manufacturer made a dosing decision for you and baked it into the powder. If the evidence or your goals would point toward more of one component and less of another, a blend can’t accommodate that — your only lever is total draw volume, which moves everything together.

This matters more because the underlying evidence is thin. As we cover in the companion piece on the BPC-157 and TB-500 stack rationale, the synergy stories behind popular combos are hypotheses drawn from separate animal studies — no controlled human trial has tested these combinations, or often either ingredient alone. So a blend commits you to a specific ratio that nobody has actually validated.

Honest caveats

• Most research peptides are not approved for human use. They are sold as research chemicals, and purity, identity, and labeled quantity are frequently unverified. If the milligrams on the label are wrong, every number above is wrong too.
• Blends compound the uncertainty. You inherit the unknowns of each peptide, plus the interaction no one has studied, plus a fixed ratio you can’t adjust.
• The math is not a safety endorsement. Calculating a dose tells you what’s in a draw; it says nothing about whether taking it is a good idea. Before going near any of this, read our peptide safety framework for how to think about sourcing, evidence, and risk.

The takeaway

A blend vial is one solution containing a fixed mixture, reconstituted with a single water volume. Each peptide’s concentration is its mg divided by that shared volume, and any draw delivers each peptide as concentration times the draw’s volume — which is why the ingredients always come out in the same locked ratio. You dose the blend as a whole; you can’t tune the parts. Run your specific numbers through the Peptide Blend Calculator to see the per-peptide breakdown, keep the evidence limits firmly in mind, and treat all of this as educational rather than a protocol to follow.

Sources

• U.S. FDA — Compounding and bulk drug substances (Category 2 nominations), on the regulatory status of peptides like BPC-157 and thymosin beta-4 (TB-500)
• General reconstitution and U-100 insulin-syringe conversion conventions (1 unit = 0.01 mL on a 100-unit syringe)